Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Synovate steve lowery 1

Steve Lowery joins Synovate

January 6, 2010 Sales and Marketing appointment, sales and marketing, synovate

Marketing intelligence agency Synovate has appointed Steve Lowery group head, custom healthcare, in the UK. Lowery joins Synovate from Kantar …
Appointment
Witty

GSK’s Andrew Witty appointed president of EFPIA

January 5, 2010 Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
Appointment

Novartis to acquire majority stake in Alcon

January 5, 2010 Sales and Marketing Alcon, Novartis, eye care

Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …
News

Lilly extends remit for finance chief Derica Rice

January 5, 2010 Sales and Marketing appointment, lilly, sales and marketing

Lilly’s senior vice president and chief financial officer Derica Rice has taken on an expanded role. He becomes executive vice …
Appointment
Roche's new Building 1

Roche plans striking new Basel offices

January 4, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Basel, Roche, construction

Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …
News

Serge Weinberg joins board at Sanofi-Aventis

January 4, 2010 Research and Development, Sales and Marketing Sanofi-Aventis, appointment, research and development, sales and marketing

Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Appointment

Celgene

January 1, 2010 Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Feature
lung cancer

New approaches in lung cancer

January 1, 2010 Sales and Marketing lung cancer

Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …
Feature
The European Medicines Agency concedes greater engagement is needed

Patient involvement must improve, says European regulator

December 31, 2009 Sales and Marketing EMEA, patients

The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …
News

Promising new drugs could bypass UK approval process

December 23, 2009 Sales and Marketing MHRA, MISG, hta, market access

UK patients could next year be given access to drugs that are still in the later stages of clinical development, …
News

Pharma mergers and acquisitions in 2009

December 22, 2009 Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Feature
US healthcare reform demonstrators

US health reform heads for decisive vote

December 22, 2009 Sales and Marketing Obama, Senate, US healthcare

The US Senate has passed new healthcare legislation, giving President Barack Obama signs of progress on reform in both parliamentary …
News

Sanofi’s Plavix combination recommended for European approval

December 21, 2009 Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
News

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009 Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Appointment
BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009 Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026